HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jugdutt, B. I. Articles by Callaghan, J. C. Search for Related Content PubMed PubMed Citation Articles by Jugdutt, B. I. Articles by Callaghan, J. C.

The Journal of Thoracic and Cardiovascular Surgery, Vol 74, 20-27, Copyright © 1977 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Long-term survival after tricuspid valve replacement. Results with seven different prostheses

BI Jugdutt, RS Fraser, SJ Lee, RE Rossall and JC Callaghan

The experience with tricuspid valve replacement (TVR) with seven different prostheses, alone or combined with replacement of other valves, in 73 patients (64 rheumatic and nine nonrheumatic) between 1964 and March, 1975, at the University of Alberta Hospital has been reviewed. Early and late mortality rates in rheumatic patients were 41 and 23 percent, respectively (36 percent being alive after a mean of 5.6 years), compared to 33 and 11 percent, respectively, in the nonrheumatic patients (56 percent being alive after a mean of 2 years). Of all survivors, 88 percent were functionally improved. Among the rheumatic patients: (1) 88 percent had organic tricuspid disease; (2) of the 39 patients with tricuspid insufficiency who underwent corrective mitral surgery 7 years before TVR, the tricuspid insufficiency had progressed over the 7 years; (3) the number of patients with tricuspid insufficiency had increased (39 versus 59) over the same 7 year period; (4) a high early mortality rate was encountered in those who were preoperatively in New York Heart Association (N.Y.H.A.) Class IV, or who had cardiomegaly, or pulmonary hypertension, or poor ventricular function, or organic disease, or reoperation; (5) the percentages of survivors with different prostheses were: Starr-Edwards, 31 percent; Beall-Surgitool, 14 percent; Kay- Shiley, 46 percent, Bjork-Shiley, 50 percent; Lillehei-Kaster, 100 percent; Cutter-Smeloff and Wada-Cutter, nil. Among the nonrheumatic patients, two with the Cutter-Smeloff, two with the Beall-Surgitool, and one with the Lillehei-Kaster were alive after 14, 37, and 15 months, respectively. Among all survivors of TVR, late thrombus and pannus developed on both ball and disc prostheses (Starr-Edwards, two; Cutter-Smeloff, one; Lillehei-Kaster, one). These findings suggest that TVR should be performed earlier in rheumatic patients to reduce the operative mortality rate and that the Lillehei-Kaster prosthesis is probably most suitable for TVR.

This article has been cited by other articles:

				S. Pande, S. K Agarwal, G. Majumdar, A. Kapoor, N. Kale, and A. Kundu Valvuloplasty in the Treatment of Rheumatic Tricuspid Disease Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 107 - 111. [Abstract] [Full Text] [PDF]

				S. Lee and B.-C. Chang Reply Ann. Thorac. Surg., October 1, 2007; 84(4): 1425 - 1425. [Full Text] [PDF]

				B.-C. Chang, S.-H. Lim, G. Yi, Y. S. Hong, S. Lee, K.-J. Yoo, M. S. Kang, and B. K. Cho Long-Term Clinical Results of Tricuspid Valve Replacement Ann. Thorac. Surg., April 1, 2006; 81(4): 1317 - 1324. [Abstract] [Full Text] [PDF]

				G. J. Van Nooten, F. Caes, Y. Taeymans, Y. Van Belleghem, K. Francois, D. De Bacquer, F. E. Deuvaert, F. Wellens, and G. Primo Tricuspid valve replacement: Postoperative and long-term results J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 672 - 679. [Abstract] [Full Text]

				K. Nakano, H. Koyanagi, A. Hashimoto, G. Ohtsuka, and C. Nojiri Tricuspid valve replacement with the bileaflet St. Jude Medical valve prosthesis J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 888 - 892. [Abstract] [Full Text]